TABLE 2.
Auto-segmentation dosimetric evaluation compared to intra- and interoperator variability
| D90% median (range) | PRO versus PRO2 (RSD%) | PRO versus RO1 (RSD%) | PRO versus RO2 (RSD%) | PRO versus model (RSD%) | |
|---|---|---|---|---|---|
| 1 | 8.9 (7.8–11.8) | 3.4 | 3.5 | 17.4 | 4.4 |
| 2 | 8.5 (8.2–10.1) | 1.6 | 1.0 | 7.3 | 8.6 |
| 3 | 8.0 (7.0–9.7) | 1.3 | 6.4 | 9.5 | 4.1 |
| 4 | 7.3 (5.0–9.3) | 12.6 | 28.3 | 2.1 | 9.9 |
| 5 | 8.5 (7.1–9.9) | 2.2 | 8.7 | 7.9 | 5.6 |
| 6 | 9.4 (7.3–10.5) | 5.4 | 12.5 | 4.1 | 7.2 |
| 7 | 8.3 (7.3–9.5) | 13.1 | 13.1 | 1.7 | 6.8 |
| 8 | 8.1 (7.6–11.9) | 1.8 | 3.4 | 18.9 | 0.3 |
| 9 | 7.2 (5.7–8.3) | 7.3 | 4.7 | 2.4 | 15.8 |
| 10 | 8.3 (5.7–8.6) | 0.4 | 18.9 | 1.6 | 4.8 |
| 11 | 8.1 (6.5–8.2) | 5.1 | 0.2 | 0.7 | 11.1 |
| 12 | 7.4 (5.5–9.1) | 1.5 | 17.9 | 10.0 | 24.8 |
| Median (range) | 2.8 (0.4–13.1) | 7.6 (0.2–28.3) | 5.7 (0.7–18.9) | 7.0 (0.3–24.8) | |
| p-Value | 0.07 | 0.002 | 0.034 | 0.126 |
Abbreviations: PRO, primary radiation oncologist; RSD, relative standard deviation.